glp-1 drugs microdosing Microdosing, Brain Health & Alzheimer's Prevention What Is Microdosing GLP-1? Full

While ertugliflozin did not outperform placebo for MACE, it significantly reduced hospitalizations for HF by 30% (59)

2021bEfficacy and Safety of dulaglutide 3.0 mg and 4.5 mg versus dulaglutide 1.5 mg in Metformin-Treated Patients with type 2 diabetes in a randomized controlled trial (AWARD-11)

The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk

More recently, the FDA has approved several GLP-1 agonists for weight loss in people with obesity who do not have diabetes

Findings This cohort study of 30 458 patients from an insurance database in the US found that compared with GLP-1 RAs, bariatric surgery was significantly associated with greater weight loss while saving approximately $11 689 in ongoing costs over 2 years

Some case reports suggest that patients on chronic hydrocortisone therapy may experience adrenal insufficiency symptoms when starting GLP-1 drugs